Lianhe Aigen

Chinese peptide CDMO offering full-service development and manufacturing of peptide therapeutics. GMP-compliant facilities. Provides SPPS, LPPS, and hybrid synthesis capabilities for clinical and commercial supply.

Lianhe Aigen is listed as a CDMO in the peptide supply chain, serving Asia markets from China. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is supported by 1 independent source, including documentation review and cross-referencing against public records. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.